An Investigator-blind, Controlled Study to Assess the Efficacy of Six Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Active Control in a Psoriasis-Plaque-Test.

Trial Profile

An Investigator-blind, Controlled Study to Assess the Efficacy of Six Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Active Control in a Psoriasis-Plaque-Test.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Betamethasone dipropionate/bexarotene (Primary) ; Antipsoriatics
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 28 Mar 2012 Planned number of patients changed from 20 to 22 as reported by European Clinical Trials Database record.
    • 28 Sep 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 28 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top